about
The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviewsInterventions for preventing influenza: an overview of Cochrane systematic reviewsInfluenza vaccines for preventing acute otitis media in infants and childrenPhysical interventions to interrupt or reduce the spread of respiratory virusesVaccines for the common coldInterventions for preventing influenza: an overview of Cochrane systematic reviewsInfluenza vaccination for healthcare workers who work with the elderlyEffectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesThe relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsSeasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature reviewInfluenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesMeasuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesTargeted vaccine selection in influenza vaccinationPreclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccineEffectiveness of influenza vaccination for preventing influenza-related complications in people with asthma: a systematic review protocolEconomic appraisal of Ontario's Universal Influenza Immunization Program: a cost-utility analysisTrends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic.Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional studyEnhancement of collective immunity in Tokyo metropolitan area by selective vaccination against an emerging influenza pandemic.Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis.Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.Adenoviral vectors as novel vaccines for influenza.Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protectionNeuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trialsInfluenza vaccines: from surveillance through production to protection.Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in EnglandImmunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.Severe influenza cases in paediatric intensive care units in Germany during the pre-pandemic seasons 2005 to 2008Novel viral vectored vaccines for the prevention of influenza.Influenza vaccination in the face of immune exhaustion: is herd immunity effective for protecting the elderly?Immunogenicity and safety of a 2009 pandemic influenza A (H1N1) monovalent vaccine in Chinese infants aged 6-35 months: a randomized, double-blind, controlled phase I clinical trial.The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation studyThe effect of universal influenza immunization on mortality and health care use.Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review.Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in childrenThe potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project.
P2860
Q21090775-A58152B9-1A5E-495F-A085-3E556FBA519DQ24193398-32C7FB17-5F5B-41D0-9071-3320ABF5EB74Q24201197-75F4B4AF-B901-4D43-B1BF-AC75620DEB1FQ24235375-D6D779A8-CB40-47AD-9989-583E626D2143Q24235521-4CBFB1FD-8152-4730-BD0F-079AEED2D2A1Q24235679-C03608C1-9424-4A0A-A490-636297A6862DQ24239966-0030CEE2-22A1-4C6F-BE5D-D174E93074B2Q24614487-30E0E51F-C4CF-4D47-BEC2-216BB2D3F014Q24622008-6E3D165F-CF2E-411C-BE9A-90CCF2E5D20EQ26769664-739A0F19-264D-4A4E-83A1-AB0AC166DC48Q26783844-15E013D9-F427-499C-9E56-BB84BF4B3F9CQ26783884-A5D0CA88-1F48-4CFB-AE6C-CDFE53F7EB49Q27030899-261F3893-2C97-4383-9FB1-F1A7D967DBF4Q27347652-54DE64E8-EC6B-408E-80CD-3F4D4CBA4EB9Q28077038-30FFEB60-04A4-4D3F-8653-1BB32B6D3ED2Q28748161-70644C84-4341-40DC-B690-10222969BE72Q30351876-690FFFC7-0F6E-4883-97D3-B0C3935E30CFQ30351936-4481D936-46D0-4E99-896F-294EBD2E861DQ30353828-4EA4D063-359E-485C-99AE-8C179D1FC9C4Q30359491-F335FEF5-FF3E-415B-8C49-9D6491DA843CQ30360483-5756F120-5F28-401A-9646-7EE522DD547DQ30370445-5090F45F-8CFB-4ED7-8A1E-2C2B6C19E2D6Q30377381-82316C1E-C703-4E01-94D0-591B6A7DE671Q30379585-5D94B9BD-09B1-4C08-89D7-CF383A90C391Q30385118-7B0A6CDA-3306-49CD-BFD7-16E825E9E4CDQ30397257-09C2A8AC-B61D-4C65-B586-1C9C2342A732Q30403801-FB173606-68C3-4C22-A8B3-B44EA388EC38Q30406437-69914DCC-5B91-40AA-9F80-D5663342E79EQ30406555-31783620-A448-474E-9D58-9332D6644A33Q30418570-041E2532-ABF6-43BE-A2D8-0849C6482383Q30422463-AFFF35E6-6C53-49F6-BEC1-464B16C1D961Q30423319-2A024DFA-5353-4B48-BF3B-0C59DE927495Q31148484-48798618-C81C-4FB8-BB3D-ECDAAE390F3CQ33380394-25CDFB1A-3FBC-47E5-9A95-F4BFB3E16CEFQ33505916-1965E688-5E40-4EF2-8589-8C9B7857703DQ33541763-3628B7B5-4A58-448C-9BA9-F8A71F343DC1Q33603662-EC4B06DD-0F42-42D4-B63F-63BBBAA55235Q33721397-2429DC7F-356B-4E0D-873C-52E6AB43943EQ33883224-F3DA2645-AC0F-4FA0-95F7-F54F6A877714Q33931458-33B65893-30A9-434E-9794-DC559DA10062
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Vaccines for preventing influenza in healthy children
@ast
Vaccines for preventing influenza in healthy children
@en
Vaccines for preventing influenza in healthy children
@en-gb
Vaccines for preventing influenza in healthy children
@nl
type
label
Vaccines for preventing influenza in healthy children
@ast
Vaccines for preventing influenza in healthy children
@en
Vaccines for preventing influenza in healthy children
@en-gb
Vaccines for preventing influenza in healthy children
@nl
prefLabel
Vaccines for preventing influenza in healthy children
@ast
Vaccines for preventing influenza in healthy children
@en
Vaccines for preventing influenza in healthy children
@en-gb
Vaccines for preventing influenza in healthy children
@nl
P2093
P2860
P3181
P1476
Vaccines for preventing influenza in healthy children
@en
P2093
Alessandro Rivetti
Anthony Harnden
Tom Jefferson
P2860
P3181
P356
10.1002/14651858.CD004879.PUB3
P577
2008-04-23T00:00:00Z